Related references
Note: Only part of the references are listed.Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study
Jonggi Choi et al.
JAMA ONCOLOGY (2019)
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
Namyoung Paik et al.
LIVER INTERNATIONAL (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Is Low Level Viremia Acceptable During Antiviral Therapy of Patients With HBV Infection and Decompensated Cirrhosis?
Norah Terrault
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B
Grace Lai-Hung Wong et al.
JOURNAL OF HEPATOLOGY (2018)
Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
Eui Joo Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Jung Hee Kim et al.
HEPATOLOGY (2017)
Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic
Toshifumi Tada et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
Hiroki Nishikawa et al.
JOURNAL OF CANCER (2017)
Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma
Tai-Chung Tseng et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
FIB-4 as a Prognostic Model for Patients With Hepatitis B-Associated Hepatocellular Carcinoma
Qing Pang et al.
HEPATOLOGY (2015)
High Liver Fibrosis Index FIB-4 Is Highly Predictive of Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Beomseok Suh et al.
HEPATOLOGY (2015)
Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2years of entecavir treatment
Seung Kak Shin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir
L. Lu et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis
Soon Sun Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis
Wenwen Jin et al.
BMC GASTROENTEROLOGY (2012)
Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders
Benjamin Yip et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
Mika Kurokawa et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma
Chuen-Fei Chen et al.
GASTROENTEROLOGY (2011)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
Beom Kyung Kim et al.
LIVER INTERNATIONAL (2010)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Share Paper
